Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
Olux Foam 0.05% (Clobetasol)
| Clobetasol Foam (Generic) Clobetasol | ||||||
|
Shipped from Canada | ||||||
| | ||||||
| Select product strength & quantity:
Who is the product for? YouOtherAdd Family Member/PetYou must be logged in to add additional members to the order. Don't have an account? or Add Family Member/PetSign inTo continue, please enter your email address and password that you use for your account. | ||||||
General Medication Fact Sheet for Olux Foam 0.05%
| Field | Information |
|---|---|
| Medication Name | Olux Foam 0.05% |
| Generic Name | Clobetasol Propionate |
| Boxed/Label Warning | Prolonged use can cause hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, hyperglycemia, and glucosuria. |
| Purpose | Treats inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. |
| Mechanism of Action | Clobetasol propionate is a highly potent corticosteroid that reduces inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability. |
| Dosage Forms | Topical Foam |
| Available Strengths | 0.05% |
| Dosage Frequency | Twice daily for up to 2 weeks, or as directed by a healthcare provider. |
| Common Side Effects | Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, secondary infection. |
| Serious Side Effects | HPA axis suppression, Cushing’s syndrome, hyperglycemia, glucosuria, glaucoma, cataracts, skin atrophy. |
| Drug Interactions | No significant drug interactions reported with topical application when used as directed. Systemic absorption may potentially interact with immunosuppressants. |
| Important Notes | For external use only. Avoid contact with eyes. Do not use on the face, groin, or axillae unless directed by a healthcare provider. Do not use occlusive dressings. Discontinue use when control is achieved. |
| Storage | Store at room temperature. Contents under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperatures above 120°F (49°C). |
| Missed Dose | Apply as soon as you remember. If it is almost time for your next dose, skip the missed dose and apply your next dose at the regular time. Do not double the dose. |
| Alternatives | Betamethasone dipropionate, Fluocinonide, Mometasone furoate, Triamcinolone acetonide. |
Olux Foam 0.05% Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Betamethasone dipropionate | Corticosteroid; reduces inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. | Available as a cream, ointment, or lotion. Different potencies available. |
| Fluocinonide | Corticosteroid; reduces inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. | Available as a cream, ointment, solution, or gel. High potency. |
| Mometasone furoate | Corticosteroid; reduces inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. | Available as a cream, ointment, or lotion. Medium potency. |
| Triamcinolone acetonide | Corticosteroid; reduces inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. | Available as a cream, ointment, lotion, or spray. Various potencies available. |
Olux Foam 0.05% Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Burning | HPA axis suppression |
| Itching | Cushing’s syndrome |
| Irritation | Hyperglycemia |
| Dryness | Glaucoma |
| Folliculitis | Cataracts |
| Acneiform eruptions | Skin atrophy |
Olux Foam 0.05% Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Corticosteroid-Responsive Dermatoses | Apply a thin layer | Apply a thin layer twice daily | Apply to affected areas. Gently rub in. Discontinue when control is achieved. Do not use occlusive dressings. |
Olux Foam 0.05% Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $25 |
| Without Insurance (U.S.) | $350 |
| From CPS | $225.95 |
